TWI734095B - DNMP KINASE AND METHOD FOR MANUFACTURING NUCLEIC ACIDS USING THE dNMP KINASE - Google Patents

DNMP KINASE AND METHOD FOR MANUFACTURING NUCLEIC ACIDS USING THE dNMP KINASE Download PDF

Info

Publication number
TWI734095B
TWI734095B TW108112727A TW108112727A TWI734095B TW I734095 B TWI734095 B TW I734095B TW 108112727 A TW108112727 A TW 108112727A TW 108112727 A TW108112727 A TW 108112727A TW I734095 B TWI734095 B TW I734095B
Authority
TW
Taiwan
Prior art keywords
dnmp
kinase
diphosphate
deoxyribonucleoside
triphosphate
Prior art date
Application number
TW108112727A
Other languages
Chinese (zh)
Other versions
TW202037602A (en
Inventor
鄭乃瑋
張晃猷
俐君 郭
Original Assignee
國立清華大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立清華大學 filed Critical 國立清華大學
Priority to TW108112727A priority Critical patent/TWI734095B/en
Publication of TW202037602A publication Critical patent/TW202037602A/en
Application granted granted Critical
Publication of TWI734095B publication Critical patent/TWI734095B/en

Links

Images

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention provides a dNMP Kinase obtained from Thermus P23 phage having the nucleic acids of SEQ ID NO: 1. The invention further provides a method for manufacturing NDP or dNDP using the dNMP kinase, comprising mixing (a) NMP or dNMP, (b) ATP or dATP, and (c) dNMP kinase under a high temperature and basic condition to product NDP or dNDP. In addition, a method for manufacturing dNTP is also provided.

Description

dNMP激酶及使用此激酶製備核苷酸的方法 dNMP kinase and method for preparing nucleotide using this kinase

本發明係有關於一種核醣核酸的製備,且特別有關於一種新穎之dNMP激酶(deoxynucleoside monphosphate)、使用此dNMP激酶製備(去氧)核醣核苷雙磷酸(NDP或dNDP)、(去氧)核醣核苷三磷酸(NTP或dNTP)的方法。 The present invention relates to the preparation of a ribonucleic acid, and particularly to a novel dNMP kinase (deoxynucleoside monphosphate), the use of this dNMP kinase to prepare (deoxy)ribonucleoside diphosphate (NDP or dNDP), (deoxy)ribose Nucleoside triphosphate (NTP or dNTP) method.

核苷酸是由一個五碳醣、含氮鹼基以及一至三個磷酸根所組成的化合物,在生物體中是相當重要的分子。就基因層面而言,去氧核醣核苷三磷酸(dNTP)可以拿來組成DNA,核醣核苷酸則用來組成RNA。在商業上,目前核苷酸已應用於食物增味劑、動物的飼料、傷口癒合及化妝品等,用途相當廣泛。 Nucleotides are compounds composed of a five-carbon sugar, a nitrogen-containing base, and one to three phosphates. They are very important molecules in organisms. At the genetic level, deoxyribonucleoside triphosphates (dNTPs) can be used to form DNA, and ribonucleotides can be used to form RNA. Commercially, nucleotides have been used in food flavor enhancers, animal feed, wound healing, cosmetics, etc., and their applications are quite wide.

隨著PCR的發展與生物技術等等的應用,dNTP在研究單位及商業應用上的需求量逐年上升,然而現今市面上所販售的dNTP主要是以化學方式合成,僅有少部分文獻記載了生物製成。 With the development of PCR and the application of biotechnology, etc., the demand for dNTPs in research units and commercial applications is increasing year by year. However, the dNTPs sold on the market today are mainly synthesized by chemical methods, and only a few documents have recorded them. Biologically made.

化學合成的方法是將dNMP鹽類以溶解性很好的二甲基甲醯胺(dimethylformamide)處理過後使用三-正丁基胺進行初步的磷酸根還化,之後再加入含氮鹼基合成dNTP,最後以吡啶pyridine進行有機相及水相的分離,整體的反應時間約2個小時,產率依照dNTP種類差異而有20%到 50%左右的差異。 The chemical synthesis method is to treat the dNMP salt with dimethylformamide, which is very soluble, and then use tri-n-butylamine for preliminary phosphate reduction, and then add the nitrogen-containing base to synthesize dNTP Finally, the organic phase and the water phase are separated with pyridine. The overall reaction time is about 2 hours. The yield varies from 20% to 20% depending on the type of dNTP. The difference is about 50%.

化學合成法在純化及分離的步驟具有很高的複雜性,需要分離未反應完的鹽類、磷酸溶液、DMF還有反應中所產生的副產物。此外,在反應中所使用的吡啶以及DMF都是有機毒物,會對人體及環境造成危害。 The chemical synthesis method has high complexity in the purification and separation steps, and it is necessary to separate unreacted salts, phosphoric acid solution, DMF and by-products produced in the reaction. In addition, the pyridine and DMF used in the reaction are organic poisons, which are harmful to the human body and the environment.

有鑑於此,為解決上述問題,業界亟需一種無環境汙染、低反應時間、高產率且簡單的dNTP合成法及系統。因此,本發明係提供一種新穎之蛋白質,其係具備dNMP激酶活性、以及使用此蛋白製備(去氧)核醣核苷雙磷酸的方法,和使用此蛋白製備(去氧)核醣核苷三磷酸的方法。 In view of this, in order to solve the above problems, the industry urgently needs a dNTP synthesis method and system that is free of environmental pollution, low reaction time, high yield, and simple. Therefore, the present invention provides a novel protein with dNMP kinase activity, a method for preparing (deoxy)ribonucleoside diphosphate using this protein, and a method for preparing (deoxy)ribonucleoside triphosphate using this protein method.

本發明係提供一種分離之蛋白質,該蛋白質具有dNMP激酶(dNMP kinase,NMK)活性,其具有SEQ ID NO:1之胺基酸序列。 The present invention provides an isolated protein which has dNMP kinase (NMK) activity and has the amino acid sequence of SEQ ID NO:1.

SEQ ID NO:1之胺基酸序列如下所示:

Figure 108112727-A0305-02-0003-1
The amino acid sequence of SEQ ID NO: 1 is shown below:
Figure 108112727-A0305-02-0003-1

在本發明一實施例中,該蛋白質為源自嗜熱菌噬菌體之蛋白質。 In an embodiment of the present invention, the protein is a protein derived from thermophilic bacteriophage.

在本發明一實施例中,該蛋白質為源自嗜熱菌P23噬菌體(Thermus P23 phage)之蛋白質。 In an embodiment of the present invention, the protein is a protein derived from Thermus P23 phage.

本發明係提供一種前述蛋白質作為激酶之用途,係用於轉換 一核醣核苷單磷酸(NMP)為一核醣核苷雙磷酸(NDP)之用途,或用於轉換一去氧核醣核苷單磷酸(dNMP)為一去氧核醣核苷雙磷酸(dNDP)之用途。 The present invention provides a use of the aforementioned protein as a kinase, which is used for conversion A ribonucleoside monophosphate (NMP) is used as a ribonucleoside diphosphate (NDP), or used to convert a deoxyribonucleoside monophosphate (dNMP) to a deoxyribonucleoside diphosphate (dNDP) use.

本發明進一步提供一種使用前述蛋白質製備核醣核苷雙磷酸或去氧核醣核苷雙磷酸的方法,包括:(i)混合(a)一核醣核苷單磷酸(NMP)或一去氧核醣核苷單磷酸(dNMP)、(b)一腺苷三磷酸(ATP)或一去氧腺苷三磷酸(dATP)及(c)前述蛋白質;以及(ii)在一高溫與一鹼性環境下進行反應,產生核醣核苷雙磷酸(NDP)或去氧核醣核苷雙磷酸(dNDP)。 The present invention further provides a method for preparing ribonucleoside bisphosphate or deoxyribonucleoside bisphosphate using the aforementioned protein, comprising: (i) mixing (a) a ribonucleoside monophosphate (NMP) or a deoxyribonucleoside Monophosphate (dNMP), (b) adenosine triphosphate (ATP) or deoxyadenosine triphosphate (dATP) and (c) the aforementioned protein; and (ii) reacting under a high temperature and an alkaline environment , To produce ribonucleoside diphosphate (NDP) or deoxyribonucleoside diphosphate (dNDP).

本發明更進一步提供一種去氧核醣核苷三磷酸(dNTP)的製備方法,包括:(i)混合一去氧核醣核苷單磷酸(dNMP)、一腺苷三磷酸(ATP)及前述蛋白質,在一高溫與一鹼性環境下進行反應,以產生去氧核醣核苷雙磷酸(dNDP);以及(ii)混合該去氧核醣核苷雙磷酸(dNDP)、一磷酸根及一磷酸轉移酶,以產生去氧核醣核苷三磷酸(dNTP)。 The present invention further provides a method for preparing deoxyribonucleoside triphosphate (dNTP), which comprises: (i) mixing a deoxyribonucleoside monophosphate (dNMP), an adenosine triphosphate (ATP) and the aforementioned protein, Reacting under a high temperature and an alkaline environment to produce deoxyribonucleoside diphosphate (dNDP); and (ii) mixing the deoxyribonucleoside diphosphate (dNDP), monophosphate and monophosphotransferase , To produce deoxyribonucleoside triphosphate (dNTP).

在本發明一實施例中,前述磷酸根包括磷酸烯醇式丙酮酸(PEP)或乙醯磷酸(AcP)。 In an embodiment of the present invention, the aforementioned phosphate includes phosphoenolpyruvate (PEP) or acetyl phosphate (AcP).

在本發明一實施例中,磷酸轉移酶包括丙酮酸激酶或乙酸激酶。 In an embodiment of the present invention, the phosphotransferase includes pyruvate kinase or acetate kinase.

在本發明一實施例中,前述高溫環境為50℃以上。 In an embodiment of the present invention, the aforementioned high temperature environment is above 50°C.

在本發明一實施例中,前述高溫環境為50~75℃。 In an embodiment of the present invention, the aforementioned high-temperature environment is 50-75°C.

在本發明一實施例中,前述高溫環境為80~100℃。 In an embodiment of the present invention, the aforementioned high temperature environment is 80-100°C.

在本發明一實施例中,前述鹼性環境為pH6.5以上。 In an embodiment of the present invention, the aforementioned alkaline environment is above pH 6.5.

在本發明一實施例中,前述鹼性環境為pH 6.5~9。 In an embodiment of the present invention, the aforementioned alkaline environment is pH 6.5-9.

在本發明一實施例中,前述鹼性環境為pH 5~7。 In an embodiment of the present invention, the aforementioned alkaline environment is pH 5-7.

第1圖為本發明生物反應合成法之一實施例示意圖。 Figure 1 is a schematic diagram of an embodiment of the biological reaction synthesis method of the present invention.

第2圖顯示本發明嗜熱菌P23噬菌體NMK在不同pH值下的酵素活性。 Figure 2 shows the enzyme activity of the thermophilic bacterium P23 phage NMK of the present invention at different pH values.

第3圖顯示本發明嗜熱菌P23噬菌體NMK在不同溫度下的酵素活性。 Figure 3 shows the enzyme activity of the thermophilic bacterium P23 phage NMK of the present invention at different temperatures.

第4A-4D圖為高效能液相層析儀的紫外線(UV)圖譜。以高效能液相層析儀分析嗜熱菌P23噬菌體NMK所生成的去氧腺苷雙磷酸(dADP)、去氧胸腺苷雙磷酸(dTDP)、去氧胞苷雙磷酸(dCDP)及去氧鳥苷雙磷酸(dGDP)。 Figures 4A-4D are the ultraviolet (UV) spectra of the high performance liquid chromatograph. Analysis of deoxyadenosine diphosphate (dADP), deoxythymidine diphosphate (dTDP), deoxycytidine diphosphate (dCDP) and deoxygenated by the thermophilic bacterium P23 phage NMK by high performance liquid chromatography Guanosine Diphosphate (dGDP).

第5A-5D圖為高效能液相層析儀的紫外線(UV)圖譜。以高效能液相層析儀分析二磷酸激酶(NDP kinase,NDK),以嗜熱菌P23噬菌體NMK所生成的dNDP作為反應原料,以生成去氧腺苷雙磷酸(dATP)、去氧胸腺苷雙磷酸(dTTP)、去氧胞苷雙磷酸(dCTP)及去氧鳥苷雙磷酸(dGTP)。 Figures 5A-5D are the ultraviolet (UV) spectra of the high performance liquid chromatograph. Analyze NDP kinase (NDK) by high performance liquid chromatography, and use dNDP produced by thermophilic bacterium P23 phage NMK as the raw material to generate deoxyadenosine diphosphate (dATP) and deoxythymidine Diphosphate (dTTP), Deoxycytidine Diphosphate (dCTP) and Deoxyguanosine Diphosphate (dGTP).

第6A-6B圖為1%瓊脂凝膠電泳分析圖。本發明嗜熱菌P23噬菌體NMK所合成之dNTP可進行PCR反應。 Figures 6A-6B are 1% agarose gel electrophoresis analysis images. The dNTP synthesized by the thermophilic bacterium P23 phage NMK of the present invention can be subjected to PCR reaction.

本發明係提供一種分離之蛋白質,其具有dNMP激酶(dNMP kinase,NMK)之活性。本發明之分離之蛋白質自嗜熱菌P23噬菌體(Thermus P23 phage),具有SEQ ID NO:1所示之胺基酸序列。 The present invention provides an isolated protein which has the activity of dNMP kinase (NMK). The isolated protein of the present invention is derived from Thermus P23 phage and has the amino acid sequence shown in SEQ ID NO:1.

SEQ ID NO:1之胺基酸序列如下所示:

Figure 108112727-A0305-02-0006-3
The amino acid sequence of SEQ ID NO:1 is shown below:
Figure 108112727-A0305-02-0006-3

本發明提供分離之蛋白質,包含SEQ ID NO:1所示之胺基酸序列,進一步包含該蛋白質的變異體,所述蛋白質的變異體係指具有一或多個胺基酸取代、刪除或添加後所衍生之該蛋白質,且該蛋白質同樣具備dNMP激酶之活性,所述蛋白質的變異體及其用途,應視為等同本發明均等範圍。 The present invention provides an isolated protein comprising the amino acid sequence shown in SEQ ID NO: 1, and further comprising variants of the protein. The variant system of the protein refers to having one or more amino acid substitutions, deletions or additions. The derived protein, and the protein also has the activity of dNMP kinase, the variants of the protein and its use should be regarded as equivalent to the scope of the present invention.

本發明dNMP激酶的氨基酸序列中具有高比例的精氨酸(Arg),有良好的熱穩定性。Arg的側鏈分支中的胍基團(guanidinium group)利用共振(resonance)的方式與周圍的胺基酸形成穩定的氫鍵,而且Arg也含有一個亞甲基基團,可增強胺基酸間的疏水性作用力,這些鍵結都對結構的熱穩定性有幫助。此外,Arg的解離常數(pKa)最高可達12,在高溫下能以帶電荷的形態存在,維持與附近胺基酸的鍵結與作用力來穩定蛋白質的結構與熱穩定性。 The amino acid sequence of the dNMP kinase of the present invention has a high proportion of arginine (Arg), and has good thermal stability. The guanidinium group in the side chain branch of Arg uses resonance to form a stable hydrogen bond with the surrounding amino acid, and Arg also contains a methylene group, which can strengthen the amino acid The hydrophobic force, these bonds are helpful to the thermal stability of the structure. In addition, Arg has a dissociation constant (pKa) of up to 12, and can exist in a charged form at high temperatures, maintaining the bond and force with nearby amino acids to stabilize the structure and thermal stability of the protein.

在一實施例中,本發明dNMP激酶的Arg比例為8.5%以上,較佳為6~8%,更佳為8~12%。 In one embodiment, the Arg ratio of the dNMP kinase of the present invention is 8.5% or more, preferably 6-8%, more preferably 8-12%.

本發明dNMP激酶具有良好的活性可將dNMP或NMP轉化成dNDP或NDP。在一實施例中,本發明dNMP激酶具有熱穩定性及活性,特別是在50℃~65℃時具有良好活性。 The dNMP kinase of the present invention has good activity and can convert dNMP or NMP into dNDP or NDP. In one embodiment, the dNMP kinase of the present invention has thermal stability and activity, especially good activity at 50°C to 65°C.

在另一實施例中,本發明在pH6.5~7.0時具有良好活性。 In another embodiment, the present invention has good activity at pH 6.5 to 7.0.

本發明另提供一種使用本發明dNMP激酶製備核醣核苷雙磷酸(NDP)或去氧核醣核苷雙磷酸(dNDP)的方法。本發明之方法包括:混合(a)核醣核苷單磷酸(NMP)或去氧核醣核苷單磷酸(dNMP)、(b)一腺苷三磷酸(ATP)或去氧腺苷三磷酸(dATP)以及(c)本發明之dNMP激酶,在一高溫、鹼性環境下進行反應,產生核醣核苷雙磷酸(NDP)或去氧核醣核苷雙磷酸(dNDP)。 The present invention also provides a method for preparing ribonucleoside diphosphate (NDP) or deoxyribonucleoside diphosphate (dNDP) using the dNMP kinase of the present invention. The method of the present invention includes: mixing (a) ribonucleoside monophosphate (NMP) or deoxyribonucleoside monophosphate (dNMP), (b) monoadenosine triphosphate (ATP) or deoxyadenosine triphosphate (dATP) ) And (c) The dNMP kinase of the present invention reacts in a high temperature and alkaline environment to produce ribonucleoside diphosphate (NDP) or deoxyribonucleoside diphosphate (dNDP).

本發明所述之核醣核苷雙磷酸(NDP)包括腺苷雙磷酸(ADP)、胸腺苷雙磷酸(TDP)、胞苷雙磷酸(CDP)及/或鳥苷雙磷酸(GDP);去氧核醣核苷雙磷酸(dNDP)包括去氧腺苷雙磷酸(dADP)、去氧胸腺苷雙磷酸(dTDP)、去氧胞苷雙磷酸(dCDP)及/或去氧鳥苷雙磷酸(dGDP)。 The ribonucleoside diphosphate (NDP) of the present invention includes adenosine diphosphate (ADP), thymidine diphosphate (TDP), cytidine diphosphate (CDP) and/or guanosine diphosphate (GDP); deoxy Ribonucleoside diphosphate (dNDP) includes deoxyadenosine diphosphate (dADP), deoxythymidine diphosphate (dTDP), deoxycytidine diphosphate (dCDP) and/or deoxyguanosine diphosphate (dGDP) .

在本發明中,可使用腺苷三磷酸(ATP)或去氧腺苷三磷酸(dATP)作為磷酸根的來源。在一高溫、鹼性環境下與本發明之dNMP激酶,進行反應,將核醣核苷單磷酸(NMP)或去氧核醣核苷單磷酸(dNMP)轉換成核醣核苷雙磷酸(NDP)或去氧核醣核苷雙磷酸(dNDP)。 In the present invention, adenosine triphosphate (ATP) or deoxyadenosine triphosphate (dATP) can be used as a source of phosphate. Under a high temperature and alkaline environment, it reacts with the dNMP kinase of the present invention to convert ribonucleoside monophosphate (NMP) or deoxyribonucleoside monophosphate (dNMP) into ribonucleoside diphosphate (NDP) or to remove Oxyribonucleoside diphosphate (dNDP).

本發明方法中所述之“高溫”係指50℃以上、50~60℃、60~70℃、70~80℃、80~90℃以及、90~100℃。 The "high temperature" mentioned in the method of the present invention refers to above 50°C, 50~60°C, 60~70°C, 70~80°C, 80~90°C, and 90~100°C.

本發明方法中所述之“鹼性”係指pH5以上、pH5~6.5、pH6.5~7、pH7~8、pH8~9。 The "alkaline" mentioned in the method of the present invention refers to pH 5 or higher, pH 5 to 6.5, pH 6.5 to 7, pH 7 to 8, pH 8 to 9.

本發明更提供一種去氧核醣核苷三磷酸(dNTP)的製備方法,此方法包括2步驟,第1步驟為產生去氧核醣核苷雙磷酸(dNDP),第2步驟為產生去氧核醣核苷三磷酸(dNTP),如第1圖示。 The present invention further provides a method for preparing deoxyribonucleoside triphosphate (dNTP). The method includes two steps. The first step is to produce deoxyribonucleoside diphosphate (dNDP), and the second step is to produce deoxyribonucleotide nuclei. Glycoside triphosphate (dNTP), as shown in Figure 1.

第1步驟與上述使用本發明dNMP激酶製備去氧核醣核苷雙 磷酸(dNDP)的方法相同。將去氧核醣核苷單磷酸(dNMP)與本發明之dNMP激酶混合,以去氧腺苷三磷酸(dATP)作為磷酸根的來源,在一高溫、鹼性環境下進行反應,可產生去氧核醣核苷雙磷酸(dNDP)。 The first step is the same as described above using the dNMP kinase of the present invention to prepare deoxyribonucleoside double The method of phosphoric acid (dNDP) is the same. Mixing deoxyribonucleoside monophosphate (dNMP) with the dNMP kinase of the present invention, using deoxyadenosine triphosphate (dATP) as the source of phosphate, reacts under a high temperature and alkaline environment to produce deoxygenation Ribonucleoside Diphosphate (dNDP).

第2步驟為將第1步驟所獲得的去氧核醣核苷雙磷酸(dNDP)與一磷酸根物質及一磷酸轉移酶在65℃水浴槽混和反應10分鐘,以產生去氧核醣核苷三磷酸(dNTP)。第2步驟中所使用的磷酸根物質可包括,例如,磷酸烯醇式丙酮酸(PEP)或乙醯磷酸(AcP),且磷酸轉移酶可包括,例如丙酮酸激酶或乙酸激酶。將所獲得的去氧核醣核苷三磷酸(dNTP)純化後,即可獲得高純度的去氧核醣核苷三磷酸(dNTP)。 The second step is to mix and react the deoxyribonucleoside diphosphate (dNDP) obtained in the first step with monophosphate and monophosphotransferase in a 65°C water bath for 10 minutes to produce deoxyribonucleoside triphosphate (dNTP). The phosphate substance used in the second step may include, for example, phosphoenolpyruvate (PEP) or acetyl phosphate (AcP), and the phosphotransferase may include, for example, pyruvate kinase or acetate kinase. After the obtained deoxyribonucleoside triphosphate (dNTP) is purified, high-purity deoxyribonucleoside triphosphate (dNTP) can be obtained.

本發明之方法為一生物合成方法,相較以往的化學合成,僅只需要兩種酵素(dNMP激酶、丙酮酸激酶或乙酸激酶)就可以進行dNTP的生物合成,且整體反應的時間也大幅降低(僅需約40分鐘)。此外,因為是在高溫環境下反應,可以抑制許多環境中酵素的活性(如磷酸水解酶),減少其他可能會影響dNTP合成的因素。在產率方面,dNTP的產率可以達到50%以上,較佳為55%、60%、65%、70%、75%、76%、77%、78%、79%、80%以上,相較以往的酵素合成方法高出許多。 The method of the present invention is a biosynthetic method. Compared with the previous chemical synthesis, only two enzymes (dNMP kinase, pyruvate kinase or acetate kinase) are required to carry out dNTP biosynthesis, and the overall reaction time is also greatly reduced ( It only takes about 40 minutes). In addition, because the reaction is performed in a high temperature environment, it can inhibit the activity of enzymes in many environments (such as phosphohydrolase) and reduce other factors that may affect dNTP synthesis. In terms of yield, the yield of dNTPs can reach more than 50%, preferably 55%, 60%, 65%, 70%, 75%, 76%, 77%, 78%, 79%, 80% or more. It is much higher than the previous enzyme synthesis method.

實施例Example

實施例1. 嗜熱菌P23噬菌體NMK的製備Example 1. Preparation of thermophilic bacteria P23 phage NMK

將嗜熱菌P23噬菌體之NMK的基因片段經由PCR擴增反應後,由限制酶NdeI和XhoI酵切處理,接合到蛋白質的表現載體pET-30a(Novagen)上,並轉形至大腸桿菌BL21中,以進行表現。 After the NMK gene fragment of the thermophilic bacteriophage P23 phage was amplified by PCR, it was digested with restriction enzymes NdeI and XhoI, ligated to the protein expression vector pET-30a (Novagen), and transformed into E. coli BL21 For performance.

可理解的,製備蛋白質係為本發明所屬技術領域之慣用技術,是以其他製備蛋白質之方法,應視為等同本發明均等範圍。 It is understandable that protein preparation is a common technique in the technical field to which the present invention belongs, and other methods for preparing proteins should be regarded as equivalent to the scope of the present invention.

實施例2. 嗜熱菌P23噬菌體NMK最佳活性測定Example 2. Determination of the best activity of thermophilic bacteria P23 phage NMK

取1μg經純化的嗜熱菌P23噬菌體NMK,加入不同pH值(pH6.5、pH 7、pH 7.5、pH 8及pH 8.5)的反應溶液(50mM Tris-HCl;80mM KCL;8mM MgCl2;5mM dNMP;2mM ATP),在不同溫度(55℃、60℃、65℃、70℃及75℃)的水浴槽反應30分鐘。產物以高效層析儀進行分析。 Take 1μg of purified thermophilic bacteriophage P23 phage NMK and add reaction solutions (50mM Tris-HCl; 80mM KCL; 8mM MgCl 2 ; 5mM) of different pH values (pH 6.5, pH 7, pH 7.5, pH 8 and pH 8.5) dNMP; 2mM ATP), react in a water bath at different temperatures (55°C, 60°C, 65°C, 70°C and 75°C) for 30 minutes. The product was analyzed by a high-performance chromatograph.

參照第2圖,在溫度65℃的情況下,在pH 8.5的情況下具有最佳的活性。與pH 8.5的活性(100%)相比,在pH 8.0時活性為86%,在pH 7.5的活性為85%,在pH 7.0的活性為74%,且在pH 6.5的活性為73%。結果顯示在pH值7到8.5之間嗜熱菌P23噬菌體NMK都還能保有70%左右的活性。 Referring to Figure 2, at a temperature of 65°C, it has the best activity at a pH of 8.5. Compared with the activity at pH 8.5 (100%), the activity at pH 8.0 was 86%, the activity at pH 7.5 was 85%, the activity at pH 7.0 was 74%, and the activity at pH 6.5 was 73%. The results showed that the thermophilic bacteriophage P23 phage NMK can retain about 70% of the activity between pH 7 and 8.5.

由第3圖可知,嗜熱菌P23噬菌體NMK在70℃時有最佳活性。與70℃的活性(100%)相比,在75℃的活性為45%,在65℃的活性為95%,在60℃的活性為72%,且在55℃的活性為55%。結果顯示在溫度70℃到65℃之間有著最好的活性,且發現嗜熱菌P23噬菌體NMK對溫度有很強烈的敏感性,在最佳活性以外的溫度,活性都降低至50%左右。 It can be seen from Figure 3 that the thermophilic bacteriophage P23 phage NMK has the best activity at 70°C. Compared with the activity at 70°C (100%), the activity at 75°C is 45%, the activity at 65°C is 95%, the activity at 60°C is 72%, and the activity at 55°C is 55%. The results show that it has the best activity at a temperature between 70°C and 65°C, and the thermophilic bacteriophage P23 phage NMK is found to be very sensitive to temperature. At temperatures other than the optimal activity, the activity is reduced to about 50%.

實施例3. 嗜熱菌P23噬菌體NMK的活性Example 3. The activity of thermophilic bacteria P23 phage NMK

取最終濃度1μg/μL經純化後的NMK,加入反應溶液(50mM Tris-HCl;80mM KCL;8mM MgCl2;5mM dNMP;2mM ATP或dATP;pH 8.0),反應總體積為100μl,反應溫度為65℃,在水浴槽反應30分鐘後獲得產物。使用Water X-BridgeTM C18管柱(4.6 x 20mm,顆粒大小3μm),在37°C恆溫環境下以高效層析儀分析產物。 Take the purified NMK at a final concentration of 1μg/μL and add the reaction solution (50mM Tris-HCl; 80mM KCL; 8mM MgCl 2 ; 5mM dNMP; 2mM ATP or dATP; pH 8.0), the total reaction volume is 100μl, the reaction temperature is 65 ℃, the product was obtained after 30 minutes of reaction in a water bath. Using Water X-BridgeTM C18 column (4.6 x 20mm, particle size 3μm), the product was analyzed with a high-performance chromatograph at a constant temperature of 37°C.

由第4A-4D圖可知,不論是以ATP或dATP為磷酸根來源,在以dAMP、dTMP、dCMP或dGMP作為受質的情況下,嗜熱菌P23噬菌體NMK可產生dADP、dTDP、dCDP或dGDP。 It can be seen from Figures 4A-4D that whether ATP or dATP is used as the source of phosphate and dAMP, dTMP, dCMP or dGMP is used as the substrate, the thermophilic bacteriophage P23 NMK can produce dADP, dTDP, dCDP or dGDP .

實施例4. 利用嗜熱菌P23噬菌體NMK合成dNTPExample 4. Synthesis of dNTPs using thermophilic bacteriophage P23 phage NMK

取最終濃度4μg/μL純化的嗜熱菌P23噬菌體NMK加入含有反應溶液(50mM Tris-HCl;80mM KCL;8mM MgCl2;5mM dNMP;2mM ATP;pH 8.0)的微量離心管中,反應總體積為400μl,於65℃反應30分鐘。之後再加入最終濃度4μg/μL純化之Me.thermophileTh.maritima的乙酸激酶(acetate kinase,AK)或T.thermophilus hb8的丙酮酸激酶(pyruvate kinase,PK),並提供最終濃度2mM磷酸根(AcP或PEP),然後在65℃水浴槽反應10分鐘。 Take the purified thermophilic bacteriophage P23 NMK at a final concentration of 4μg/μL and add it to the microcentrifuge tube containing the reaction solution (50mM Tris-HCl; 80mM KCL; 8mM MgCl 2 ; 5mM dNMP; 2mM ATP; pH 8.0). The total reaction volume is 400μl, react at 65°C for 30 minutes. Then add a final concentration of 4μg/μL purified Me.thermophile , Th.maritima acetate kinase (AK) or T.thermophilus hb8 pyruvate kinase (pyruvate kinase, PK), and provide a final concentration of 2mM phosphate ( AcP or PEP), and then react in a 65°C water bath for 10 minutes.

由第5A-5D圖可知,透過二磷酸激酶(NDP kinase,NDK),以ATP提供磷酸根,再以嗜熱菌P23噬菌體NMK生成的dADP、dTDP、dCDP或dGDP作為受質的情況下,可產生dADP、dTDP、dCDP或dGDP,反應及其結果皆與先前技術相同。 From Figures 5A-5D, it can be seen that when ATP provides phosphate through NDP kinase (NDK), and dADP, dTDP, dCDP or dGDP produced by the thermophilic bacteriophage P23 phage NMK as the substrate, it can be To produce dADP, dTDP, dCDP or dGDP, the reaction and results are the same as the prior art.

取20μl反應後的產物作為dNTP的來源,並以PCR擴增進行檢測。PCR產物以1%瓊脂凝膠進行電泳分析。參照第6A-6B圖,本發明嗜熱菌P23噬菌體NMK所合成之dNTP確實可來進行PCR使用。 Take 20μl of the reaction product as the source of dNTP, and use PCR amplification for detection. The PCR products were analyzed by electrophoresis on 1% agar gel. Referring to Figures 6A-6B, the dNTP synthesized by the thermophilic bacterium P23 phage NMK of the present invention can indeed be used for PCR.

<110> 國立清華大學 <110> National Tsing Hua University

<120> dNMP激酶及使用此激酶製備核苷酸的方法 <120> dNMP kinase and method for preparing nucleotides using this kinase

<160> 1 <160> 1

<170> PatentIn version 3.5 <170> PatentIn version 3.5

<210> 1 <210> 1

<211> 177 <211> 177

<212> PRT <212> PRT

<213> Thermus virus P23 <213> Thermus virus P23

<400> 1

Figure 108112727-A0305-02-0011-4
Figure 108112727-A0305-02-0012-5
<400> 1
Figure 108112727-A0305-02-0011-4
Figure 108112727-A0305-02-0012-5

Claims (1)

一種分離之蛋白質製備核醣核苷三磷酸或去氧核醣核苷三磷酸的方法,包括:(i)混合(a)一核醣核苷單磷酸(NMP)或一去氧核醣核苷單磷酸(dNMP)、(b)一腺苷三磷酸(ATP)或一去氧腺苷三磷酸(dATP)及(c)一分離之蛋白質;以及(ii)在一高溫環境下進行反應,產生一核醣核苷雙磷酸(NDP)或一去氧核醣核苷雙磷酸(dNDP);其中,該分離之蛋白質具有SEQ ID NO:1所示之胺基酸序列;該高溫環境為65~70℃;該高溫環境為pH 7~8.5;其中該方法包括去氧核醣核苷三磷酸(dNTP)的製備步驟,包括:(iii)混合該去氧核醣核苷雙磷酸(dNDP)、一磷酸根及一磷酸轉移酶,以產生去氧核醣核苷三磷酸(dNTP),該磷酸根包括磷酸烯醇式丙酮酸(PEP)或乙醯磷酸(AcP);該磷酸轉移酶包括丙酮酸激酶或乙酸激酶。 A method for preparing ribonucleoside triphosphate or deoxyribonucleoside triphosphate from separated protein, comprising: (i) mixing (a) monoribonucleoside monophosphate (NMP) or monodeoxyribonucleoside monophosphate (dNMP) ), (b) an adenosine triphosphate (ATP) or a deoxyadenosine triphosphate (dATP) and (c) an isolated protein; and (ii) a reaction under a high temperature environment to produce a ribonucleoside Diphosphate (NDP) or deoxyribonucleoside diphosphate (dNDP); wherein the isolated protein has the amino acid sequence shown in SEQ ID NO:1; the high temperature environment is 65~70°C; the high temperature environment PH 7~8.5; wherein the method includes the steps of preparing deoxyribonucleoside triphosphate (dNTP), including: (iii) mixing the deoxyribonucleoside diphosphate (dNDP), monophosphate and monophosphotransferase , To produce deoxyribonucleoside triphosphate (dNTP), the phosphate includes phosphoenolpyruvate (PEP) or acetyl phosphate (AcP); the phosphotransferase includes pyruvate kinase or acetate kinase.
TW108112727A 2019-04-11 2019-04-11 DNMP KINASE AND METHOD FOR MANUFACTURING NUCLEIC ACIDS USING THE dNMP KINASE TWI734095B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW108112727A TWI734095B (en) 2019-04-11 2019-04-11 DNMP KINASE AND METHOD FOR MANUFACTURING NUCLEIC ACIDS USING THE dNMP KINASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108112727A TWI734095B (en) 2019-04-11 2019-04-11 DNMP KINASE AND METHOD FOR MANUFACTURING NUCLEIC ACIDS USING THE dNMP KINASE

Publications (2)

Publication Number Publication Date
TW202037602A TW202037602A (en) 2020-10-16
TWI734095B true TWI734095B (en) 2021-07-21

Family

ID=74090961

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108112727A TWI734095B (en) 2019-04-11 2019-04-11 DNMP KINASE AND METHOD FOR MANUFACTURING NUCLEIC ACIDS USING THE dNMP KINASE

Country Status (1)

Country Link
TW (1) TWI734095B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170292138A1 (en) * 2016-04-06 2017-10-12 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170292138A1 (en) * 2016-04-06 2017-10-12 Greenlight Biosciences, Inc. Cell-free production of ribonucleic acid

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Bao Jie et al., "Total biosynthesis of deoxynucleoside triphosphates using deoxynucleoside monophosphate kinases for PCR application" Biotechnology and bioengineering 98.1: 1-11, 2007/05/18
NCBI accession no. YP_001467881, dNMP kinase [Thermus virus P23-45], 2018/08/13
NCBI accession no. YP_001467881, dNMP kinase [Thermus virus P23-45], 2018/08/13 Bao Jie et al., "Total biosynthesis of deoxynucleoside triphosphates using deoxynucleoside monophosphate kinases for PCR application" Biotechnology and bioengineering 98.1: 1-11, 2007/05/18 許翼軒,Thermus thermophilus HB8核苷酸激酶與核苷二磷酸激酶基因之選殖與應用於去氧核醣核苷三磷酸之合成,國立清華大學分子醫學研究所碩士論文,上架日:2019/03/27 *
許翼軒,Thermus thermophilus HB8核苷酸激酶與核苷二磷酸激酶基因之選殖與應用於去氧核醣核苷三磷酸之合成,國立清華大學分子醫學研究所碩士論文,上架日:2019/03/27

Also Published As

Publication number Publication date
TW202037602A (en) 2020-10-16

Similar Documents

Publication Publication Date Title
US20210261998A1 (en) Compositions and methods related to nucleic acid preparation
CN107567501B (en) Compositions and methods relating to nucleic acid synthesis
US9790540B2 (en) Methods and kits for 3′-end-tagging of RNA
EP3630965B1 (en) Use of terminal transferase enzyme in nucleic acid synthesis
US11623940B2 (en) Methods of nucleic acid synthesis comprising polyphosphate containing species
EP2812441A1 (en) Nucleic acid ligation method
JP2024028962A (en) COMPOSITIONS AND METHODS FOR ORDERED AND CONTINUOUS COMPLEMENTARY DNA (cDNA) SYNTHESIS FROM NON-CONTINUOUS MULTIPLE TEMPLATES
TWI734095B (en) DNMP KINASE AND METHOD FOR MANUFACTURING NUCLEIC ACIDS USING THE dNMP KINASE
JP7010489B2 (en) Method for processing double-stranded DNA ends
EP1624059A2 (en) Method of producing nucleic acid molecules with reduced secondary structure
US20230235373A1 (en) Controlled template-independent synthesis of nucleic acids using thermostable enzymes
US10487357B2 (en) Methods of nucleic acid analysis using terminator nucleotides
Akram et al. Bacterial thermophilic DNA polymerases: A focus on prominent biotechnological applications
WO2021250265A2 (en) Ab-initio, template-independent synthesis of nucleic acids using thermostable enzymes
JPH09505736A (en) Nucleoside analog method
Ledbetter et al. Site-Specific Labeling of DNA via PCR with an Expanded Genetic Alphabet
Arnold et al. Single-nucleotide resolution of RNA strands in the presence of their RNA complements
Morihiro et al. Polymerase incorporation of a 2′-deoxynucleoside-5′-triphosphate bearing a 4-hydroxy-2-mercaptobenzimidazole nucleobase analogue
CN101705270A (en) Method for synthesizing deoxycytidine triphosphate through biotechnology
WO2016153999A1 (en) Modified nucleotides and uses thereof
Motter et al. A deamination-driven biocatalytic cascade for the synthesis of ribose-1-phosphate
WO2023111180A1 (en) Variants of thermostable dna primases and uses thereof
Park et al. Selectivity and Efficiency of the Ligation of The Pyrene: Abasic Base Pair by T4 DNA Ligase: Towards Abasic Lesion Detection by Ligation
CN104513850A (en) Deoxyribonuclease catalysis synthesis method
JP2010523078A (en) Modified polynucleotides containing ribose rings